Results 141 to 150 of about 21,306 (257)

Myointimal hyperplasia of the mesenteric veins mimicking inflammatory bowel disease in a 13-year-old patient. [PDF]

JPGN Rep
Abuquteish D, Chami R, Chavhan GB, Walters T, Siddiqui I.   +4 more
europepmc   +1 more source

Feasibility and Outcomes of a Robotic Retroperitoneal Approach to Para‐Aortic Lymphadenectomy in Intermediate‐ and High‐Risk Endometrial Cancer: A Prospective Study

The International Journal of Medical Robotics and Computer Assisted Surgery, Volume 22, Issue 2, April 2026.
ABSTRACT Background This prospective feasibility study evaluated the safety and efficacy of robotic retroperitoneal para‐aortic lymphadenectomy in patients with intermediate‐to high‐risk endometrial cancer. Methods Patients with endometrial cancer who underwent robotic surgical staging at Mie University Hospital between October 2021 and May 2025 were ...
Michiko Kubo‐Kaneda, Kenta Yoshida, Saki Kotaka, Asumi Okumura, Tsuyoshi Mastumoto, Kota Okamoto, Eiji Kondo   +6 more
wiley   +1 more source

BRTO for ectopic small intestinal varices bleeding via dilated superior mesenteric veins and left ovarian vein: A case report. [PDF]

Radiol Case Rep
You Y, Wang W, Zhong J, Chen S.
europepmc   +1 more source

Inferior mesenteric vein

, 2016
Sajith Karunasena, Liz Silverstone, Ciléin Kearns   +2 more
openaire   +1 more source

Tacrolimus Induced Hypertension and Vascular Remodeling Includes Mechanisms of Cellular Senescence—The Protective Effect of Valsartan

Acta Physiologica, Volume 242, Issue 4, April 2026.
ABSTRACT Aim Calcineurin inhibitors (CNI) such as tacrolimus (Tac) are the first‐line treatment to prevent transplant rejection. However, CNI have adverse effects on blood vessels and renal function, which may be linked to cellular senescence. Valsartan, a common angiotensin II type 1 receptor (AT1R) blocker, exhibits anti‐senescence properties.
Lingyan Fei, Xiaohua Wang, Lingyi Kong, Tianjiao Cui, Pratik H. Khedkar, Yunxiu Xiang, Dongliang Zhao, Junxuan Fang, Yulin Liang, Yangyang Zhang, Nan Xu, Xingyu Qiu, Liang Zhao, Gensheng Zhang, Yan Lei, Chun Tang, Kongyang Ma, Liwei Lu, Jin Wei, En Yin Lai, Pontus B. Persson, Andreas Patzak, Zhihua Zheng, Shan Jiang   +23 more
wiley   +1 more source

Multidetector computer tomography and magnetic resonance imaging of double superior mesenteric veins: A case report. [PDF]

World J Clin Cases
Tang W, Peng S.
europepmc   +1 more source

Idiopathic Myointimal Hyperplasia of the Mesenteric Veins. [PDF]

ACG Case Rep J, 2016
Patel AD, Schneider Y, Saumoy M, Maltz C, Yeo H, Jessurun J, Wan D.   +6 more
europepmc   +1 more source

Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 7, Page 967-978, April 2026.
Diabetes mellitus independently increases the risk of hepatic encephalopathy following TIPS placement in patients with cirrhosis. These findings emphasize the need for careful risk assessment in patients with cirrhosis and portal hypertension complications undergoing TIPS.
Michelle Spaan, Ellen Werner, Willemijn Dijkstra, Nicole E. Erler, Diederik Bijdevaate, Sarwa Darwish Murad, Milan J. Sonneveld, Caroline M. den Hoed, Anne van Eldere, Dave S. Sprengers, Willem‐Pieter Brouwer, Robert J. de Knegt, Harry L. A. Janssen, Kay Pieterman, Sandra Coenen, Raoel Maan, Adriaan J. van der Meer   +16 more
wiley   +1 more source

Superior mesenteric vein thrombosis

South African Journal of Radiology, 2006
A Brandt, B Louw, G Dekker, S Hlongwane, M Pienaar   +4 more
openaire   +3 more sources

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

International Journal of Laboratory Hematology, Volume 48, Issue 2, Page 259-271, April 2026.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source